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Abstract 
In this study, we compare the release mechanisms from nanocomposite hydrogels. Liposomes made of 
different compositions of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dihexadecanoyl-sn-
glycero-3-phosphocholine (DPPC), nanogels made of chitosan-hyaluronic acid association and crosslinked 
nanogels made of N-isopropylacrylamide (NIPAM) and different ratios of methacrylic acid (MAA) were 
embedded in acrylamide hydrogels with a model drug, either sulforhodamine B or rhodamine 6G. 
Liposomes demonstrated the capacity to release their payload over 10 days while NIPAM nanogels and 
chitosan nanogels released within one or two days. We found that liposomes embedded in hydrogels 
presented two distinctive release mechanisms, a diffusive burst and a slower “sub-diffusive” release. Both 
nanogels on the other side presented no observable nor defined affinity-based release mechanism due to 
presence of salts, completely screening electrostatic interactions. The present work highlights critical points 
related to the release mechanisms from nanocomposite hydrogels as drug delivery devices or as biomedical 
tools for tissue engineering or regenerative medicine. 
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Highlights: 
  Nanostructured hydrogels with nano-inclusions or with affinity nano-domains are proposed as 
drug release systems 
  Nano-inclusions and affinity domains are finely tuned and well characterized 
  Key release mechanisms were identified for nano-inclusion-based hydrogels 








Pharmaceutical science is recently taking a path where engineered systems for drug delivery are increasing 
in complexity. However, over the past two decades, significant advancements have occurred in the field of 
nanotechnology that have led to the development of nanoscaled particles with specific physical and 
chemical properties beneficial for therapeutic purposes [1]. Nanoparticles were first engineered as drug 
controlled-release systems to facilitate administration and improve therapeutic efficiency. Yet, more 
recently, nanoparticles have started being used along with hydrogels as novel biocompatible drug delivery 
platforms as well as innovative biomaterials for tissue engineering and regenerative medicine, generally 
referred to as nanocomposite hydrogels. Indeed, nanoparticles can provide adhesion or affinity domains 
[2], nano-inclusions [3], confer stimulus-responsiveness [4] or increase mechanical properties of the gel 
[5]. 
Basically, these new features mostly depend on nanoparticles-hydrogel combinations and can lead to 
greater flexibility in design such as interpenetrated networks, nano-domains within the hydrogel or in 
organized scaffolds. The complexity and stimulus-responsiveness of nanocomposite hydrogels might open 
new versatile and tunable controlled drug delivery devices. These nano-domains can add specific ability to 
use triggers or stimuli to achieve a desired response which in some cases can react faster than in the bulk 
[6-8]. Therefore, they are highly relevant for a broad range of applications from pharmaceutical (patches, 
implants or tissue engineered platforms) [9, 10] to environmental applications (chemical removal) [11]. 
Additionally, their modified mechanical properties enhanced from nanoparticles would also make them an 
appealing material for skin or cartilage replacement [5]. 
While the complexity degree of these materials is increasing, it gets harder to define which composition is 
better or optimal for a specific purpose. In this study, we focused toward the comparison of nanocomposite 
hydrogels of various natures to achieve a controlled delivery of an active compound. For this purpose, we 
used three types of nanoparticles, i.e. liposomes, chitosan nanogels and NIPAM nanogels, embedded in 
hydrogels to create nano-inclusions or affinity domains. Indeed, the use of nano-inclusions from liposomes 
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to nanogels have been suggested via broad range of applications [12]. However, nanogel nano-inclusions 
have been mostly reported for their capacity to tune hydrogel mechanical properties [8]. Only a few studies 
report their ability to control the release of a molecule [13-16].    
Liposomes are often regarded as one of the most successful nanocarriers because of their ability to provide 
controlled release, prolonged effect and temperature sensitivity [17-19]. We used liposomes as nano-
inclusions and as a typical diffusion-based release system because of their structure made from a 
phospholipid bilayer and different phospholipid compositions, as first described by Alec Bangham [17]. 
Crosslinked gel nanoparticles based on poly N-isopropylacrylamide (pNIPAM) and N,N’-methylene-
bis(acrylamide) (bisA)  copolymers also have drawn interest for their thermosensitive and pH-sensitive 
features [20]. Introduced by Pelton and Chibante by polymerization of NIPAM and BisA [21], these 
crosslinked gel nanoparticles can also include a negative charge in their polymeric structure with the 
copolymerization of NIPAM and methacrylic acid (MAA). However, MAA inclusion alters some of the 
nanoparticle properties such as lowering the critical solubility temperature (LCST) and pH-responsiveness 
[22-24]. In this report, embedded NIPAM nanogels (200-600 nm) in hydrogels were used to create affinity 
and responsive domains. 
Finally, we also studied nanogels made from the ionic gelation of polycationic chitosan with polyanionic 
hyaluronic acid (HA) and sodium tripolyphosphate (TPP) due to their bioactivity, biodegradability and 
biocompatibility that make them ideal material for in vivo applications [25]. Their components are 
biorelevant and possess a highly-charged matrix from natural polyelectrolytes [26-30] which was found to 
be advantageous in terms of active compound delivery [31] and regenerative medicine [32].  
Controlling the release of an active compound among drug delivery devices is mandatory since 
invasive administration routes in almost every circumstance would benefit from sustained release 
by reducing dosage frequency and improving current treatments. For instance, implants, drug-
loaded patches and tissue-designed platforms are potential applications of nanocomposite hydrogels 
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but require a biocompatible polymeric matrix to entrap particles capable of sustaining and 
controlling the release of the active substance [33, 34]. In order to produce these nanocomposite 
hydrogels, a model hydrogel of acrylamide/bisA with high water content was used to represent 
biocompatible or tissue-mimicking synthetic matrices for the embedment of nanocarriers. The 
combined structure of different nanogels and the acrylamide hydrogel result in a semi-
interpenetrated network as already reported [7]. The objectives of this study were to compare all 
three particle formulations in their capacity to control the release of a model compound. Previous 
studies have focused on describing the release mechanism of plain hydrogels as a diffusion-based 
or affinity-based release system and recent reports show interesting mathematical model to describe 
the release mechanism [35, 36]. However, such works, to our knowledge, have never been translated 
to embedded particles within hydrogel networks with the objective to compare both affinity-based 
and diffusion-based nano-inclusions. Also, we highlight the release of liposomal particles which 
have never been considered prior to this study. Since the nano-inclusions used in this study have 
different stimulus-responsiveness, the impact of temperature, medium salinity and composition 
were also assessed. Thus, the comparison of these three different nanocarriers embedded in 
hydrogels contributes to the understanding of the various release mechanisms found with those 
complex systems and illustrates how their structure can influence their release behavior. 
2. Materials and methods 
2.1 Chemicals and reagents 
All chemicals and reagents were of analytical grade and used without further purifications. 
Phospholipids including 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-
dihexadecanoyl-sn-glycero-3-phosphocholine (DPPC) were purchased from Avanti Polar Lipids 
(Alabaster, AL, USA). Surfactant triton X-100, Sephadex® G-50, acrylamide, N-
Isopropylacrylamide (NIPAM), N,N’-methylene-bis(acrylamide) (BisA), methacrylic acid (MAA) 
with 250 ppm inhibitor MEHQ, sodium dodecyl sulfate (SDS) approx 95% and 4-(2-hydroxyethyl)-
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1-piperazineethanesulfonic acid (HEPES) were purchased from Sigma–Aldrich (Oakville, ON, 
Canada). Chitosan (Mw= 88 kDa) derived from shrimp shells and hyaluronic acid sodium salt (Mw 
= 1 400 kDa) extracted from Streptococcus equi sp were purchased from Sigma (Oakville, ON, 
Canada). Sodium tripolyphosphate (TPP) and Kiton Red S (Sulforhodamine B) were purchased 
from Alfa Aesar (Ward Hill, MA, USA). Rhodamine 6G was acquired from Acros Organics (New 
Jersey, USA). Citric acid was purchased from Anachemia (Canada). Ammonium persulfate (APS) 
was from Fisher-Biotech (Canada). Irgacure ® 2959 was supplied by BASF (Switzerland). 
 
2.2 Preparation of formulations 
2.2.1 Liposome preparation 
Preparation of liposomes was adapted from Monnard et al [37].  20 mg of (DOPC:DPPC) mixture 
were dissolved in 1 mL of chloroform in order to prepare three different batches with DOPC:DPPC 
molar ratios of (50:50), (60:40), and (70:30). Then, the solvent was slowly removed by rotary 
evaporation to form a thin lipid film at the bottom of the flask. The lipid film was dried under 
vacuum to eliminate the residual solvent content. 1 mL of sulforhodamine B (30 mM) in HEPES 
buffer (5 mM HEPES with 150 mM NaCl) was added to the flask to hydrate the lipid film at 60°C 
while mixing and vortexing until complete hydration. The dispersion was then treated by 10 freeze-
thaw cycles followed by 21 cycles of extrusion (Avanti Mini-Extruder; Avanti Polar Lipids, USA) 
through a 200-nm then a 100-nm pore size polycarbonate membrane. Non-encapsulated 
sulforhodamine B was removed from the liposomes by size exclusion chromatography with 
Sephadex® G-50 stationary phase and a HEPES buffer mobile phase. 
2.2.2 Chitosan nanogel preparation 
The chitosan nanogel formulation was prepared as described by Courant et al [38]. Briefly, CS was 
solubilized in a 10 % (w/v) citric acid aqueous solution (9 mL, pH = 2.2) at a concentration of 2.5 
mg/mL under magnetic stirring until complete dissolution. A solution of TPP (1.2 mg/mL) and HA 
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(0.8 mg/mL) was prepared in 4.5 mL Milli-Q water. Both solutions were filtered through 0.2 µm 
nylon membrane filter (Ultident Scientific, Canada). Sulforhodamine B (4 mg/mL) was then added 
to the TPP/HA solution. Subsequently, the TPP/HA solution was added dropwise to the CS solution 
on an ice bath and under ultrasonication (Fischer Scientific Sonic Dismembrator F550 Ultrasonic 
Homogenizer; power sonicator 20%) for 90 seconds. This process rapidly formed inter- and 
intramolecular electrostatic-mediated crosslinks between the polyanions and the protonated CS 
chains inducing nanoparticle formation [39]. The resulting turbid suspension was kept under 
magnetic stirring for 15 additional minutes to allow strengthening of the formed nanogels. The 
resulting loaded nanogels were stored at 4°C and protected from light exposure. Loaded nanogel 
suspensions (12 mL) were purified three times at room temperature against 1.2 L of HEPES buffer 
by the tangential flow filtration method using MicroKros® hollow fiber modules (Spectrum, 
MicroKros® ME, MWCO 0.05 µm). 
2.2.3 NIPAM-co-MAA nanogel preparation 
Thermosensitive NIPAM nanogels were prepared to provide an anionic charge (MAA) within its 
structure (NIPAM-BisA) with different charge ratios. The synthesis of the NIPAM-co-MAA 
particles was carried on with a single-step synthesis, following multiple published formulation and 
synthesis protocols [23, 40-42]. NIPAM and MAA were dissolved in degassed MilliQ water at 
different molar ratios (molMAA / [molNIPAM + molMAA]), see table 1. Then, BisA at 5.3% molar ratio 
(molMAA / [molNIPAM + molMAA+ molBisA]) and SDS at 867µmol/L were dissolved in the degassed 
solution. A total of 150 mL of monomer/crosslinker/surfactant solution was transferred into a three-
necked flask heated under reflux at approximately 60oC with constant Argon gas flow and 
mechanical stirring (275 rpm). The reaction was initiated with 10 mL APS (solution at 2.9 mmol/L) 
degassed by vacuum, while slowly increasing temperature at 75oC and maintaining argon flow rate 
and mechanically stirring the reacting solution. The reaction was stopped after 4.5 h by cooling 
down the particle suspensions at room temperature. The synthesized NIPAM nanogels were 
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purified in batches of 70 mL by two consecutive dynamic dialysis against 20 L MilliQ water for 16 
hours and 4 hours respectively, using Spectra/Por® Tube-A-Lyzer® (Rancho Dominguez, USA) 
with 100 kDa MWCO cellulose ester membrane. The nanogel suspensions were stored at 4oC until 
further use. 
 
2.3 Nanoparticle Imaging 
2.3.1 Atomic force microscopy imaging 
NIPAM nanogels (NIPAM-co-MAA10%) and chitosan nanogels (10 µL) were deposited on mica 
surfaces at a concentration of 25 µg/mL and 2.5 µg/mL respectively. The samples were left to dry 
then imaging was carried out using a Multimode Dimension 3100 AFM equipped with a NanoScope 
VIII controller (Digital Instruments) in the peak force QNM mode. A Scanasyst-air tip (silicon tip 
on nitride lever) was used for imaging the nanoparticles. The nanoparticles were imaged first on a 
large square area of (10 × 10 µm or 3 × 3 µm), then a single nanoparticle was imaged (1 × 1 µm) at 
256 scans per line resolution.  
 
2.3.2 Fluorescence microscopy imaging 
A volume of 10 µL of NIPAM nanogels and liposomes were deposited on a clean glass slide and 
covered with a cover slit. The sample was imaged using an inverted microscope (Olympus IX81) 
equipped with a Retiga 2000R CCD camera from QImaging (Surrey, Canada). The images were 
acquired at a 100× magnification using typical Texas Red filter set. Images were cropped to 
specifically select an area containing sufficient quantity of nanoparticles. Color balance was 
adjusted with ImageJ software (version 1.50b). 
2.3 Physicochemical characterization of formulations 
The size of liposomes, chitosan nanogels and NIPAM nanogels were measured using dynamic light 
scattering (DLS) using a Malvern Zetasizer NanoZS (Malvern Instruments, UK) and expressed as 
9 
 
Z-averages of the hydrodynamic diameters and polydispersity indexes (PdI). Each sample was 
analyzed in triplicate at 25°C unless otherwise specified. Water and water-citric acid (0.48 M) 
mixtures were used as reference dispersing media for liposomes and nanogels respectively. The 
NIPAM nanogel size was measured at different temperatures to characterize their thermosensitivity. 
Measurement started from 20oC, increasing with 2oC increments between each measurement, up to 
40oC in MilliQ water, phosphate buffered saline at pH 7.4 (PBS) and HEPES 5mM without salt (pH 
7.4). Zeta potential was acquired by measurement of electrophoretic mobility at 25°C, in triplicate 
for each sample (Malvern Zetasier Nano-ZS, 150 V) in MilliQ water for liposomes and nanogels. 
Zeta potentials of NIPAM nanogels were estimated in 4 mM NaCl medium at 22oC and 38oC 
(Malvern Zetasier Nano-ZS, 150 V). 
 
2.4 Determination of loading efficiency (LE%) and drug loading (DL%) 
The loading efficiencies (LE%) and the drug loadings (DL%) of all formulations were calculated 








×100                           (Eq. 2) 
Where Din is the amount (mass) of the dye loaded in the nanoparticles, Dtotal is the total amount of 
the dye introduced in the system, and NP is the amount of nanoparticles. 
2.4.1 Liposomes 
The Bartlett assay was performed to quantify the total inorganic phosphates of phospholipids, thus 
the total phospholipid content. A known volume collected from each batch of liposomes loaded 
with sulforhodamine B was appropriately diluted in HEPES buffer. The amount of loaded 
sulforhodamine B in liposomes was determined by spectrofluorimetry in triplicate (Hitachi F-2710 
fluorescence spectrophotometer) through addition of 10 µL of surfactant Triton X-100. The 
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sulforhodamine B fluorescence intensity was measured at 582 nm from an excitation wavelength 
of 563 nm at room temperature. DL% and LE% were thereafter calculated as described in equation 
1 and 2. 
2.4.2 Chitosan nanogels  
Sulforhodamine B-loaded nanogels were centrifuged at 20,000 rpm, 4°C for 90 minutes to remove 
nanogels from the aqueous suspension medium. The supernatant was collected and the amount of 
free sulforhodamine B in the supernatant was determined by fluorescence quantification, as 
abovementioned. Therefore, the amount of encapsulated sulforhodamine B was determined by 
indirect dosage and the mass of nanogels collected by freeze-drying (triplicate). Fluorescence 
intensity measurements were performed using the same parameters as with liposomes. 
 
2.4.3 NIPAM-co-MAA nanogels 
NIPAM nanogel concentration in stock solution was determined by freeze-drying after purification 
and weighting the residual polymer. Suspensions were loaded using R6G, a positively charged 
fluorescent dye which was expected to interact with the negatively-charged NIPAM-co-MAA 
nanogels. Stock solutions of NIPAM nanogels and R6G were prepared separately in milliQ water 
at 0.5 mg/mL and kept at 4oC until use. Loading occurred by incubating R6G (20, 40, 60, 80 µg/mL) 
in presence of 100 µg/mL of NIPAM nanogels in MilliQ water or in another incubation medium, 
such as HEPES without salt (pH 7.4) or HEPES with 145 mM NaCl (pH 7.4). The suspensions were 
vortexed and then incubated for 1 hour at two different temperatures (25oC and 40oC) or temperature 
cycles. Typically, the cycle started at the swollen-state temperature (0oC or 25oC) for 20 minutes 
then the suspensions were heated to 40oC for 20 minutes and finally returned to their initial 
temperature for the last 20 minutes. At the end of the incubation process, the drug-loaded NIPAM 
nanogels were centrifuged at 25,000 g for 30 minutes, at room temperature. Supernatants were 
collected then diluted 20 times. Free R6G was quantified by fluorescence, thus indirectly 
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quantifying the loaded amount. Each parameter in this study was assessed in independent triplicate 
(n = 3). DL% and LE% were calculated with equation 1 and 2, respectively. 
2.5 Hydrogel preparation 
Hydrogels were prepared by free radical photopolymerization of acrylamide and N-N’-methylene-
bisacrylamide (BisAc) in HEPES buffer (unless otherwise specified) with a cross-linker / monomer 
molar ratio of 5% [43]. The cross-linker/monomer solution was prepared at 95 mg/mL of 
acrylamide and 5 mg/mL N-N’-methylene-bisacrylamide in HEPES buffer. The stock solution was 
frozen at -80°C, degassed under vacuum for 30 minutes, then thawed and 2 mL of this solution was 
transferred into a 20-mL glass beaker. Irgacure® 2959 (2.9 mg/mL) in HEPES buffer (unless 
otherwise specified), also degassed, was added as a 300-µL polymerization mixture in the beaker. 
For liposome-, chitosan nanogel- and NIPAM nanogel- embedded hydrogels, the quantity of 
sulforhodamine B or R6G (loaded in particles) was adjusted at 270 µg per hydrogel batch. The final 
solution, 2.4 mL in total, was completed with either nanoparticle solution containing the dye or with 
water. The hydrogels were photopolymerized, covered with a glass slide, under UV lamp for 5-40 
minutes of exposure (365 nm; UVP Mercury Spot Low, 100MW Longwave). 
 
2.6 Release study from hydrogels 
Photopolymerized hydrogel disks were weighted and 5-mm diameter cylinders were sampled using 
a biopsy punch (Miltex ®). Thereafter, those pieces were accurately weighted to calculate the 
sulforhodamine B content in every piece. Those hydrogel samples were individually positioned in 
10 mL of HEPES buffer (pH 7.4) at 4°C and 37°C. At predetermined times, the incubation medium 
was entirely sampled and replaced by fresh HEPES buffer. The sampled medium was kept at 4oC 
in darkness until further analysis. 200-µL aliquots were analyzed by spectrofluorimetry (Tecan 
Safire Monochromatic Fluorescence) for each time-point. Each condition was studied in triplicate 
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(n= 3). The released dye percentage was calculated as the ratio of the cumulative released quantity 
and the quantity in the 5-mm hydrogel samples. 
3. Results and Discussion 
3.1 Preparation and characterization of liposomes 
*  Loading efficiencies and drug loading for NIPAM nanogels are given by loading in milliQ water 
and HEPES 5mM respectively (water – HEPES). ** Means of three Z-average values and their 
standard deviation. 
Three formulations with different phospholipid molar ratios (50:50, 60:40, and 70:30) were 
prepared to identify the effect of liposome composition on particle size and zeta potential (Table 1). 
Increasing DOPC concentration in the phospholipid mixture had a minor effect on the 
hydrodynamic diameters among all formulations with stable PdI values < 0.1 (Table 1). However, 
ZP values were found to increase significantly from -24.0 ± 4.0 mV in 50:50 formulations to -60.7 
± 1.6 mV along with the increase in DOPC. 
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290 ± 4 0.08 -6.3 ± 0.1 1.3 – 3.5 0.8 – 2.1 
NIPAM-co-MAA 
10% 
356 ± 4 0.04 -7.0 ± 0.2 10.4 – 38.3 5.9 – 18.7 
NIPAM-co-MAA 
12.5% 
496 ± 2 0.12 -7.2 ± 0.3 8.5 – 44.7 4.9 – 21.2 
NIPAM-co-MAA 
15% 
501 ± 10 0.12 -8.9 ± 0.1 13.9 – 49.3 7.7 – 22.8 
NIPAM-co-MAA 
20% 
512 ± 15 0.08 -10.5 ± 0.4 14.6 – 50.6 8.1 – 23.3 
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As depicted in figure 1C (left panel), liposomes appeared as small dots. Larger fluorescence spots 
correspond to aggregated liposomes on the surface of the glass slide. Table 1 shows that highest 
LE% (40%) and EE% (8%) were obtained in the formulation that exhibit equal ratios of 
DOPC:DPPC (50:50), while the lowest LE% (12%) and EE% (1%) were obtained from the 
formulation of (70:30) where DOPC content was the highest. Therefore, these findings suggest that 
(50:50) formulation is the optimal formulation to achieve the best sulforhodamine B-loaded 
liposomes. These variations in LE%, EE%, and ZP are due to the changes in the liposome membrane 
fluidity that depends on differences in both phospholipid composition and transition temperature 
among the three formulations. Since DOPC and DPPC have transition temperatures of -21°C and 
41°C (as provided by the manufacturer), respectively, DOPC is responsible for the fluidity and 
DPPC the rigidity. Owing to the presence of a double bond in the acyl chain of DOPC, increasing 
the DOPC:DPPC ratio in the formulations provided liposomes with higher bilayer membrane 
fluidity. Therefore, the liposomes with higher DOPC composition (60:40, 70:30) were not capable 
to encapsulate sufficient amounts of sulforhodamine B compared to liposomes with higher DPPC 
(50:50), due to the constant leakage of the model drug during the nanosystem formation. The same 
explanation applies to decreasing ZP values with higher DOPC composition. 
 
3.2 Chitosan nanogel characterization 
The prepared formulation of chitosan and HA nanogels loaded with surforhodamine B was initially 
characterized in terms of particle size and zeta potential (Table 1). The nanogels were small (mean 
hydrodynamic diameter ≈ 200 nm) and the particle size showed a larger distribution than for 
liposomes (PdI = 0.2). The zeta potential indicates a strong cationic charge (ZP = 46.3 ± 2.6 mV) 
on the surface of the nanogels. These findings corroborate with other reported nanogels using 
similar compositions [44, 45] thus providing interesting insights about its internal structure. Indeed, 
from these results, they seem structured in a way that HA chains mainly constitute the nanogel core, 
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whereas chitosan chains predominate at the nanogel surface, exposing their positive charges. This 
assumption is supported by other reports where it was observed that, to produce a negative surface 
charge for chitosan/HA nanogels, one has either to increase drastically the HA content [46] or to 
coat chitosan-based preformed nanogels with HA chains [47]. 
The DL and LE of sulforhodamine B were also evaluated in nanogels by indirect quantification of the 
supernatant resulting from the high-speed centrifugation of the nanogel suspensions. High LE was achieved, 
encapsulating almost all the fluorescent dye (LE = 96%) and consequently achieving also high drug loading 
(DL = 35%). The outer shell, highly concentrated in chitosan chains, as suggested by the measured ZP 
values, might have facilitated the retention of surlforhodamine B which carries a net negative charge in the 
loading conditions. This uneven distribution of polymer within the nanogel is also supported with 
observation of non spherical shape in AFM imaging (figure 1B, right panel). 
 
3.3 NIPAM-co-MAA nanogels characterization 
We have synthesized multiple chemically crosslinked nanogels using NIPAM as a reference 
structure in which we have incorporated different ratios of MAA ranging from 5% to 20%. Particle 
size (PS) and ZP were measured after purification of the suspensions. At 26oC as described in table 
1, PS increased with increasing MAA content from 203 nm (MAA 0%) to 512 nm (MAA 20%), 
while PdI remained below 0.15 for each formulation, indicating narrow distribution in pure water. 
Similarly, ZP decreased slightly with increasing MAA ratios from -6.3 ± 0.1 mV (MAA 5%) up to 
-10.5 ± 0.4 mV (MAA 20%), while pure NIPAM nanogels remained mostly neutral (ZP = -1.8 ± 




Thermosensitivity of NIPAM nanogels was also investigated between 20oC to 40oC for each 2oC 
increments. Increasing the ratio of MAA within the particles slightly shifted the LCST from 32oC to 36oC 
Figure 1. (A) Macroscopic visualization of the hydrogel structure (before and after sampling) 
and its evolution over time within the release medium. (B) AFM micrographs of NIPAM-co-
MAA 10% and HA-chitosan nanogels. (C) Fluorescence micrograph of liposomes (loaded with 




approximately, which was in accordance with other reports [48]. Collapsed state (T > LCST) was 
characterized by an approximated 50% PS reduction compared to the swollen state (T < LCST). Moreover, 
for MAA ratios higher than 12.5%, a second collapse transition was observed between temperatures 22oC 
to 26oC (Fig S1). Since PdI values remains very low (< 0.12) for high MAA content in the nanogels, it 
suggests that MAA distribution in the particles is not homogeneous, thus creating richer domains that 
exhibit different thermodynamic properties and different LSCT. As observed with AFM (figure 1), NIPAM 
nanogels exhibit a near spherical shape (also supported by fluorescence imaging) with some irregularities 
which are potentially the result of an uneven MAA incorporation within the particle. At pH 7.4 medium 
(salt free), swollen/collapsed transition was very weak (12 to 16% PS reduction for those observable). When 
salts were added (145 mM NaCl) to pH 7.4 PBS 10 mM, size transition from swollen to collapsed state was 
only slightly increased (18% to 21% PS reduction). This particle size change is consistent with the collapse 
of pNIPAM above its LCST. Ionization of carboxylic acid groups (at pH 7.4) located inside the particle 
might impede the interaction of the isopropyl groups present in NIPAM to drastically reduce the 
dehydration of the particle core in the collapsed state. Typical pKa values of pMAA have been reported 
between 5 and 6 which also supports this hypothesis [49]. Therefore, at pH 7.4, electrostatic repulsions 
within the particle are so effective that they nearly prevent the nanogel to collapse. The addition of salt to 
a pH = 7.4 weakly decrease the electrostatic repulsions of MAA which marginally increase the size ratio 
between swollen and collapsed states. Furthermore, the NIPAM without anionic functionalization 
aggregated in buffered medium pH 7.4 without salt indicating that the ionic force from HEPES 5 mM was 
sufficient to initiate the aggregation, which is an insight of a very weak colloidal stability [50].  
On the other hand, the surface charge of the NIPAM nanogels was significantly influenced by 
temperature. It was observed that increasing the temperature from 22 to 38oC increased the ZP for 
all NIPAM nanogels from MAA 0% (-1.8 to -11.8 mV) to MAA 20% (-10.5 to -16.3) as shown in 
figure S2. This behavior can be explained considering that, upon collapse, MAA functional groups 
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as well as the sulfated chain ends bearing the initiator are expelled from the core therefore increasing 
the surface charge [51]. 
 
3.4 DL, LE and affinity characterizations of NIPAM-co-MAA nanogels 
To gain more insights into the parameters driving the loading mechanism carried through 
electrostatic interactions with MAA, the characterization of DL and LE as a function of MAA 
content in nanogels, R6G / particle ratio, salt, pH and incubation temperature was performed (figure 
2 and figure S3). 
At first, NIPAM nanogels were incubated with different R6G concentrations for 1 hour at 25oC in 
pure water. DL was determined for each ratio of MAA within the nanogel as represented in figure 
2A. Only nanogels without MAA did not demonstrate significant encapsulation of R6G regardless 
the R6G/particle ratio. Increasing MAA concentrations within the NIPAM nanogels proved to 
increase the R6G loading as well, up to 16.3± 2.7 % (DL) and 32.4 ± 5.3 % (LE) with 20% MAA 
at a R6G/nanogel ratio of 0.6 (figure 2A). Noticeably, a plateau was found from a ratio of 0.6 which 
can be attributed as the saturation of all affinity domains in the nanogels. 
The effect of temperature and incubation medium on DL was also evaluated using one 
representative formulation (MAA 10%). In HEPES 5 mM (pH = 7.4) we observed an important 
amount of loaded R6G (DL = 38.0 ± 0.2%) in comparison with pure water (DL = 6.9 ± 1.6% at pH 
5.5). This increase seems directly related to the ionization of MAA carboxylic groups discussed 
earlier. No peak or plateau was reached in terms of DL in HEPES 5 mM, suggesting that it is still 
possible to increase DL with a ratio R6G/particle higher than 0.8 (fig. S3). On the contrary, the 
presence of salts in PBS 10 mM (NaCl 145 mM at pH = 7.4) totally prevented the loading of R6G 
into the NIPAM nanogel (Fig. 1B, light blue histograms), thus evidencing the electrostatic-based 
loading mechanism.  
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Thermosensitivity of the NIPAM nanogels was believed to increase the drug loading capabilities of 
the nanogel by successive swelling and collapse cycles to maximize the penetration of R6G within 
the core [42, 52]. However, for all three different incubation media and incubation temperatures, 
no significant difference on DL was found for each temperature cycle used as illustrated in figure 
S3. This result suggests that fast equilibration between inner or outer structure of the nanogels is 
reached independently of the loading protocol.  
To confirm that the NIPAM nanogels act as affinity domains via electrostatic interactions from 
MAA component, the affinity was calculated as suggested by Grosberg et al. [53]. The affinity was 




             (Eq. 3) 
Where Dad is the concentration (mmol/L) of R6G adsorbed on the nanogel, Dsol is the concentration 
(mmol/L) of free R6G remaining in solution, S is the concentration (mmol/L) of maximum 
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adsorption site and K is the affinity constant of R6G to its adsorption site (L/mmol). We used Eq. 3 
to extract the values of S and K (figure 3A) for each formulation, where K was kept constant for 
MAA>0%. 
The total affinity, Q, was defined as Q = S × K. This value was plotted as a function of MAA content 
in the nanogel (figure 3B). The result shows a linear relationship, confirming the hypothesis that 
the affinity of R6G towards the NIPAM nanogels is only mediated by electrostatic interactions. 
Additionally, the calculated affinity (Q) in HEPES was shown 6-fold (6.4 ± 0.5) higher than in pure 
water (1.1 ± 0.3), while in PBS Q is not significant (0.04 ± 0.04) as illustrated in figure 3C. These 
data clearly illustrate that the affinity of R6G was strongly modulated by the ionic strength of the 
medium and its pH. 
 
3.5 In vitro release from hydrogels embedding liposomes 
The release behaviour of sulforhodamine B from liposomes embedded into hydrogels was 
investigated in HEPES buffer at pH 7.4 at 4 °C and 37 °C during 240 h (Figure 4).  
The incorporation of liposomes into hydrogel produced a slower and controlled release of 
sulforhodamine B from all liposome formulations. In the case of the (50:50) formulation, an initial 
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burst release was observed at both temperatures in contrast to the release from liposome suspensions 
(described in supplementary information). At 4 °C, the cumulative release of sulforhodamine B 
started at t = 24h with 30.4±2.8% of total sulforhodamine B and was very slow until t =144h when 
the release started to increase at cumulative release of 40.0±2.9%. At t= 240h, only 52.4±2.9% of 
the total quantity of sulforhodamine B loaded within the hydrogel was released. Correspondingly, 
the (50:50) formulation showed great sensitivity towards the rise in temperature (37oC) represented 
Figure 4. Release behavior of sulforhodamine B from hydrogels embedding liposomes. 
Sulforhodamine B release tested during 240 hours (A) from hydrogels embedding three different 
formulations (free SRB – reversed triangles, 70:30 DOPC:DPPC – squares, 60:40 DOPC:DPPC -  
circles, 50:50 DOPC:DPPC – upright triangles)  of liposomes at 4 °C (dashed lines) and 37 °C (full 
lines). An increase in sulforhodamine B release rate from the (60:40) formulation following 
addition of 1% C12E9 surfactant, suggesting liposome release from the hydrogels at 4 °C and 37 
°C for over 240 hours (B). Proposed release mechanism of liposomes and sulforhodamine B from 
hydrogels at different time intervals (C).  
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by the change of the cumulative release profile compared to 4 °C. After 24h of incubation at 37 °C, 
49.8±1.0% of sulforhodamine B were diffused from the hydrogel and continued to diffuse until 
79.2±4.7% were released after t= 240h. 
The release behaviour from hydrogels for the 60:40 formulation was also extended until t= 240h 
with superior control compared to liposomes alone. Similar to the 50:50 formulation, a significant 
burst release (30-50%) was followed by a steady increased release rate every 24h at both 
temperatures. However, with increased DOPC concentration in this formulation, the release was 
found less affected by temperature. The release at 37oC (97.5±3.6% after t= 240 h) compared to the 
release at 4 °C (86.2±3.2%) after t= 240 h was only slightly faster for the former temperature.  
Due to the same factors as in the (60:40) formulation, the release from hydrogels embedding the 
70:30 formulation loaded with sulforhodamine B was very rapid but still slower than the release of 
free sulforhodamine B from the hydrogels. Those hydrogels released all their free sulforhodamine 
B content after t= 24 h, while in case of the 70:30 formulation, the release was almost completed 
after t= 48 h at both 4 °C and 37 °C. 
The burst release observed with each nanocomposite hydrogel formulations (figure 4A) was not 
found in liposome suspensions (figure S4). However, the UV light used to polymerize the hydrogels 
was tested on liposome suspensions and was found to cause leakage of sulforhodamine via 
oxidation or thermal heating of the lipids (supplementary information). Consequently, the burst 
observed can be attributed to the free sulforhodamine B in the hydrogel. 
Finally, to verify whether intact liposomes have been released from the hydrogels, 10 µL of 1% of 
nonaethylene glycol monododecyl ether (C12E9) detergent were added to the collected supernatants. 
Results showed an increase of the fluorescence intensity in each sample collected suggesting that the 
supernatants did not only contain free sulforhodamine B, but loaded liposomes as well. As seen in figure 
4B, liposomes are already released from the hydrogel shortly after incubation started, which suggests that 
they were located close to hydrogel-medium interface as depicted in figure 4C. Diffusion of liposomes 
through the hydrogel network is facilitated by the particle and polymer network deformability. Indeed, 
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liposome Young’ modulus (~3 kPa) confers high flexibility to the particle [54]. The hydrogels are expected 
to have a Young’s modulus of a similar magnitude (~ 50 kPa), with a porosity of about 30-40 nm for this 
specific hydrogel formulation [55].  
3.6 In vitro release from hydrogel embedding NIPAM nanogels 
Release of R6G in a HEPES buffer (HEPES 5 mM + NaCl 145 mM) from NIPAM nanogels was 
studied over 72 hours at both 37°C and 4oC (figure 5). In each case, the release profiles presented 
two different processes. When the cumulative release was past a definite percentage (approximately 
60-70%), the release rate was drastically reduced (figure 5A). This “break point” was evaluated by 




The loading medium of the NIPAM nanogels was first investigated, where loaded NIPAM nanogels 
in pure water were compared to loaded NIPAM nanogels in HEPES 5mM. With different drug 
loadings observed in the final hydrogels, it was expected that the final hydrogels would carry 
different quantities of affinity domains, resulting in a difference in release rates. Nanogels loaded 
in HEPES 5mM (figure 5A) initially released their content quickly, within 5 to 25 hours at 37oC, 
releasing between 58-82% R6G until reaching the “break-point”. Similarly, nanogels loaded in pure 
water (figure S5) released 64-71% R6G in 4 to 8 hours. Finally, hydrogels containing free R6G 
initially released slightly faster in comparison to hydrogels embedding NIPAM nanogels at 
respective incubation temperatures, releasing their content in 4-8 hours (63-66%). Despite a fast 
release at 37oC, the hydrogels embedding NIPAM nanogels loaded in HEPES buffer demonstrated 
the ability to release their content over 10.7 hours, extending the release period compared to 
hydrogels containing free R6G, which released over 4.0 h until the “break point” was reached. 
Similarly, nanogels loaded in pure water also resulted in a “break point” at 8.3 h. These results 
suggest that the R6G loading medium did not impact significantly on R6G release rate and 
mechanisms. Also, no clear correlation between the release rate and the MAA concentrations was 
found (figure 4A). However, the presence of the NIPAM nanogels suggests a slight reduction in the 
release rate. Those observations might be explained by the difference of affinity in the R6G loading 
medium (water / HEPES with no salt) in comparison with the release medium (buffered saline 
solution). The medium change might have drastically impacted the affinity of R6G to the nanogels, 
thus releasing without attractive force from the MAA groups, leaving no clear differences between 
formulations.  
For the purpose of studying temperature effects and better understanding the release mechanisms, 
release profiles were also evaluated at 4oC for 72 h (figures 4A dotted lines and S5). Under those 
conditions, R6G was initially released up to 58-72% for each formulation, typically releasing within 
11 - 25 h (table 2). Comparatively, the nanogels loaded in pure water released 64-69% of their total 
content in 7-9 hours and free R6G released 65.8% within 7.6 h until reaching the “break point”. 
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Release at 4oC additionally supports the hypothesis of increased sustained release using NIPAM 
nanogels which exhibited an additional 3-17 extra hours of release (nanogels loaded in HEPES for 
instance) comparatively to free R6G. This can be explained by the viscosity of the buffered saline 
at 4oC, decreasing the R6G diffusion through the hydrogel network. Additionally, it is possible that 
the NIPAM nanogel thermosensitivity has influenced the R6G release rates. Since the embedding 
hydrogel is polymerized at room temperature, the NIPAM nanogels are trapped in their swollen 
state, but at temperature of 37oC (release temperature), the NIPAM nanogels collapse, expelling 
R6G and leaving possible micropores within the hydrogel, thus facilitating further R6G release.  
 
3.7 Release from hydrogel embedding chitosan nanogels 
Release from nanogels of chitosan and HA was performed by the same method. Release of 
sulforhodamine was evaluated at both 4°C and 37oC. The resulting release kinetics represented in 
figure 4B was compared to hydrogel containing free sulforhodamine B). Chitosan nanogels released 
sulforhodamine B in a more controlled fashion than free sulforhodamine B. For instance, nanogels 
released 73.7±2.0% over a period of 48h at 37oC and 64.4±3.8% in the same timeframe at 4oC, 
whereas the same amount of free sulforhodamine B was released twice as fast (table S1).  Although, 
a high burst effect (21-29%) was observed initially at the first time-point, suggesting an immediate 
release of sulforhodamine B upon swelling in the incubation medium. Once more, exposure to low 
temperature decreased the release rate by reducing to 9% the cumulative sulforhodamine B release 
at 4oC. Such results suggest that the nanogel inclusions significantly impacted on the release profiles 
of the hydrogel by altering its release pattern in a controlled fashion. 
 
3.8 Comparison of nanogel-based and liposome-based systems  
The choice of two different drug models was motivated by the encapsulation mechanism. Indeed, 
both model drugs are encapsulated via electrostatic forces. Sulforhodamine B is negatively charged 
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at pH = 7.4 (pka = 4.2) which favors its encapsulation in chitosan-based nanogels. On the other 
hand, rhodamine 6G is positively charged at physiological pH (pKa = 10) which facilitates its 
encapsulation in negatively charged microgels. Due to the higher solubility of sulforhodamine B 
compared to rhodamine 6G, the former was chosen as a model drug for the liposome-based 
formulations. 
In order to identify key differences in the release mechanisms between the different systems tested 






                        (Eq. 4) 
Where t is the release time (in hours), L the thickness of the hydrogel (in cm), D the effective 
diffusion coefficient (cm2/s), K the affinity constant (mM-1) of the drug to the particle and CNP the 
concentration of particles / binding sites (mM).  
For the liposome-based systems, we considered that K<<1 which simplified the expression of t*. 






) 1/2           (Eq. 5) 
Where CR% corresponds to the cumulative release of the drug. For the liposome-based systems 
(Figure 6A), the release profile follows two linear (therefore purely diffusive) regimens. The first 
one, which is superimposed to the release of the free drug, corresponds to the release of mobile 
liposomes and free drug in the proximal region of the interface. The second regimen (called 
subdiffusive regimen), which corresponds to the diffusion of the drug through the liposome 
membrane and the hydrogel network, is quickly reached for all the tested formulations. These 
findings also support the proposed release mechanisms with nanocomposite hydrogels made from 
liposomes, depicted in figure 4C, where the release is performed in two distinct steps. 
Using the same renormalization of the data, NIPAM nanogels exhibited a strikingly different 
behavior (Figure 6B). These affinity-based systems also present an initial burst release mostly 
dominated by diffusion which stops abruptly after reaching approximately 65% of release. After 
this point, all the NIPAM nanogels-embedded hydrogels seem to slowly evolve towards a sub-
diffusive regimen, not reached in our experiments. 
Finally, normalisation of chitosan nanogels proved to be a relatively similar system to the NIPAM 
nanogel system (Figure 6B). In a similar fashion, nanogels despite containing important quantity of 
polyelectrolytes also proved to be massively affected by salts within the release medium. Although, 
one difference is observable with the drug used. While SRB had a very similar diffusion rate as 
R6G (widely known in water), the latter seemed to adsorb slightly more importantly to the hydrogel 
matrix than SRB, which can be seen at approximately 65% of cumulative release. This latter point 
also suggests the presence of the second sub-diffusive release step whilst using NIPAM nanogels 
and its absence in nanogels. 
Liposome nano-inclusions proved to be very efficient to prolong the release period as demonstrated 
in figure 4. However, the use of NIPAM or chitosan nanogels nano-inclusion as an affinity-based 
release systems seemed to be limited by the presence of salt ions. A possible way to counter balance 
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this effect could be by increasing the quantity of particles [15, 55], much higher than what we used 
in this study. 
4. Conclusion 
In this study, we were able to observe and clearly identify different release mechanisms for each 
nanoparticle formulation embedded in hydrogels. The combination of liposomes and hydrogels 
provided the best controlled release of the active, due to its two diffusive regimens: the first 
diffusive regimen was characterized by free sulforhodamine B dispersed within the hydrogel matrix 
and the second “sub-diffusive” regimen characterized by sulforhodamine B entrapped within 
liposomes. Nanogels made of NIPAM, however, did not impact significantly the release of R6G 
due to salt interactions from the release medium with the affinity domains. Two release mechanisms 
were also identified: first, the release of free R6G of the hydrogel matrix (burst) and then a sub-
diffusive regimen where R6G bound to the hydrogel matrix slowly diffuses into the external 
medium. As for chitosan nanogels, they exhibited a similar release profile as to NIPAM nanogels 
minus the second sub-diffusive regimen due to the choice of the released molecule. Overall, we 
have precisely described the release mechanisms of each nanocomposite hydrogel formulation we 
developed. In the light of these results, it is possible to assert that, to achieve controlled release, the 
diffusion-based mechanism is by far superior, while the affinity-based one, such as electrostatic 
interactions, could still need further improvement as a drug delivery system within a biological 
system. We still believe that the affinity-based ones hold significant potential in pharmaceutical 
applications and in nanomedicine due to their ability to tune finely the affinity domains. 
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